Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles
US Stock Market Move | Elmet Group (ELMT.US) debuts on the US stock market, opening with a more than 40% increase.
Market chaos exacerbates business uncertainty, American shale oil executives' dissatisfaction with the Trump administration is growing.
US Stock Market Move | Announcing the finalization of a $7.5 billion lease agreement, Applied Digital (APLD.US) surged more than 13%.
US Stock Market Move | Elmet Group (ELMT.US) debuts on the US stock market, opening with a more than 40% increase.
Market chaos exacerbates business uncertainty, American shale oil executives' dissatisfaction with the Trump administration is growing.
US Stock Market Move | Announcing the finalization of a $7.5 billion lease agreement, Applied Digital (APLD.US) surged more than 13%.
RECOMMEND
The Great Transformation Of The Hong Kong Automotive Market
23/04/2026
Another “Elephant” Dances As China Construction Bank Hits A Record High While The Sector Remains Below Book Value, With Several Names Offering Elevated Dividend Yields
23/04/2026
Major Oil Traders Warn One Billion Barrel Shortfall Is Locked In, Hormuz Closure Could Trigger Recession
23/04/2026
